P53 Inhibition in Pancreatic Progenitors Enhances the Differentiation of Human Pluripotent Stem Cells into Pancreatic β-Cells

Overview

Journal Stem Cell Rev Rep

Publisher Springer

Specialty Cell Biology

Date 2023 Jan 27

PMID 36707464

Authors

Idil I Aigha

Essam M Abdelalim

Affiliations

Soon will be listed here.

Abstract

The multipotent pancreatic progenitor cells (MPCs) co-expressing the transcription factors, PDX1 and NKX6.1, are the source of functional pancreatic β-cells. The aim of this study was to examine the effect of p53 inhibition in MPCs on the generation of PDX1/NKX6.1 MPCs and pancreatic β-cell generation. Human embryonic stem cells (hESCs) were differentiated into MPCs and β-cells. hESC-MPCs (stage 4) were treated with different concentrations of p53 inhibitors, and their effect was evaluated using different approaches. NKX6.1 was overexpressed during MPCs specification. Inhibition of p53 using pifithrin-μ (PFT-μ) at the MPC stage resulted in a significant increase in the number of PDX1/NKX6.1 cells and a reduction in the number of CHGA/NKX6.1 cells. Further differentiation of MPCs treated with PFT-μ into pancreatic β-cells showed that PFT-μ treatment did not significantly change the number of C-Peptide+ cells; however, the number of C-PEP+ cells co-expressing glucagon (polyhormonal) was significantly reduced in the PFT-μ treated cells. Interestingly, overexpression of NKX6.1 in hESC-MPCs enhanced the expression of key MPC genes and dramatically suppressed p53 expression. Our findings demonstrated that the p53 inhibition during stage 4 of differentiation enhanced MPC generation, prevented premature endocrine induction and favored the differentiation into monohormonal β-cells. These findings suggest that adding a p53 inhibitor to the differentiation media can significantly enhance the generation of monohormonal β-cells.

Citing Articles

Advancements and challenges in stem cell transplantation for regenerative medicine.

Wei L, Yan W, Shah W, Zhang Z, Wang M, Liu B Heliyon. 2024; 10(16):e35836.

PMID: 39247380 PMC: 11379611. DOI: 10.1016/j.heliyon.2024.e35836.

References

Memon B, Abdelalim E . Differentiation of Human Pluripotent Stem Cells into Pancreatic Beta-cell Precursors in a 2D Culture System. J Vis Exp. 2022; (178). DOI: 10.3791/63298. View

Schisler J, Jensen P, Taylor D, Becker T, Knop F, Takekawa S . The Nkx6.1 homeodomain transcription factor suppresses glucagon expression and regulates glucose-stimulated insulin secretion in islet beta cells. Proc Natl Acad Sci U S A. 2005; 102(20):7297-302. PMC: 1091752. DOI: 10.1073/pnas.0502168102. View

Schaffer A, Taylor B, Benthuysen J, Liu J, Thorel F, Yuan W . Nkx6.1 controls a gene regulatory network required for establishing and maintaining pancreatic Beta cell identity. PLoS Genet. 2013; 9(1):e1003274. PMC: 3561089. DOI: 10.1371/journal.pgen.1003274. View

Ribeiro D, Kvist A, Wittung-Stafshede P, Hicks R, Forslow A . 3D-Models of Insulin-Producing β-Cells: from Primary Islet Cells to Stem Cell-Derived Islets. Stem Cell Rev Rep. 2017; 14(2):177-188. DOI: 10.1007/s12015-017-9783-8. View

Johnson J, Ahmed N, Luciani D, Han Z, Tran H, Fujita J . Increased islet apoptosis in Pdx1+/- mice. J Clin Invest. 2003; 111(8):1147-60. PMC: 152933. DOI: 10.1172/JCI16537. View

Abdelalim E, Bonnefond A, Bennaceur-Griscelli A, Froguel P . Pluripotent stem cells as a potential tool for disease modelling and cell therapy in diabetes. Stem Cell Rev Rep. 2014; 10(3):327-37. DOI: 10.1007/s12015-014-9503-6. View

Ferreira A, Kosik K . Accelerated neuronal differentiation induced by p53 suppression. J Cell Sci. 1996; 109 ( Pt 6):1509-16. DOI: 10.1242/jcs.109.6.1509. View

Memon B, Karam M, Al-Khawaga S, Abdelalim E . Enhanced differentiation of human pluripotent stem cells into pancreatic progenitors co-expressing PDX1 and NKX6.1. Stem Cell Res Ther. 2018; 9(1):15. PMC: 5781269. DOI: 10.1186/s13287-017-0759-z. View

Strom E, Sathe S, Komarov P, Chernova O, Pavlovska I, Shyshynova I . Small-molecule inhibitor of p53 binding to mitochondria protects mice from gamma radiation. Nat Chem Biol. 2006; 2(9):474-9. DOI: 10.1038/nchembio809. View

10.

Komarov P, Komarova E, Kondratov R, Coon J, Chernov M, Gudkov A . A chemical inhibitor of p53 that protects mice from the side effects of cancer therapy. Science. 1999; 285(5434):1733-7. DOI: 10.1126/science.285.5434.1733. View

11.

Uhlemeyer C, Muller N, Rieck M, Kuboth J, Schlegel C, Griess K . Selective ablation of P53 in pancreatic beta cells fails to ameliorate glucose metabolism in genetic, dietary and pharmacological models of diabetes mellitus. Mol Metab. 2022; 67:101650. PMC: 9791454. DOI: 10.1016/j.molmet.2022.101650. View

12.

Wang X, Kua H, Hu Y, Guo K, Zeng Q, Wu Q . p53 functions as a negative regulator of osteoblastogenesis, osteoblast-dependent osteoclastogenesis, and bone remodeling. J Cell Biol. 2005; 172(1):115-25. PMC: 2063539. DOI: 10.1083/jcb.200507106. View

13.

Atkinson M, Eisenbarth G, Michels A . Type 1 diabetes. Lancet. 2013; 383(9911):69-82. PMC: 4380133. DOI: 10.1016/S0140-6736(13)60591-7. View

14.

Ryan E, Lakey J, Rajotte R, Korbutt G, Kin T, Imes S . Clinical outcomes and insulin secretion after islet transplantation with the Edmonton protocol. Diabetes. 2001; 50(4):710-9. DOI: 10.2337/diabetes.50.4.710. View

15.

Abdelalim E . Modeling different types of diabetes using human pluripotent stem cells. Cell Mol Life Sci. 2020; 78(6):2459-2483. PMC: 11072720. DOI: 10.1007/s00018-020-03710-9. View

16.

Jiang Y, Chen C, Randolph L, Ye S, Zhang X, Bao X . Generation of pancreatic progenitors from human pluripotent stem cells by small molecules. Stem Cell Reports. 2021; 16(9):2395-2409. PMC: 8452541. DOI: 10.1016/j.stemcr.2021.07.021. View

17.

Verhoeff K, Cuesta-Gomez N, Jasra I, Marfil-Garza B, Dadheech N, Shapiro A . Optimizing Generation of Stem Cell-Derived Islet Cells. Stem Cell Rev Rep. 2022; 18(8):2683-2698. DOI: 10.1007/s12015-022-10391-3. View

18.

Gibly R, Graham J, Luo X, Lowe Jr W, Hering B, Shea L . Advancing islet transplantation: from engraftment to the immune response. Diabetologia. 2011; 54(10):2494-505. PMC: 3193607. DOI: 10.1007/s00125-011-2243-0. View

19.

Freije A, Molinuevo R, Ceballos L, Cagigas M, Alonso-Lecue P, Rodriguez R . Inactivation of p53 in Human Keratinocytes Leads to Squamous Differentiation and Shedding via Replication Stress and Mitotic Slippage. Cell Rep. 2014; 9(4):1349-60. DOI: 10.1016/j.celrep.2014.10.012. View

20.

Li H, Liu J, Wang Y, Fu Z, Huttemann M, Monks T . MiR-27b augments bone marrow progenitor cell survival via suppressing the mitochondrial apoptotic pathway in Type 2 diabetes. Am J Physiol Endocrinol Metab. 2017; 313(4):E391-E401. PMC: 5668595. DOI: 10.1152/ajpendo.00073.2017. View